Cost Plus Drugs CEO Alex Oshmyansky TK on the latest episode of the “Rapid Response” podcast.

Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still ...

At a time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

Mark Cuban (entrepreneur, investor, and founder, Cost Plus Drugs) joins Chris Cuomo to discuss disrupting Big Pharma, ...

Shares of Vincerx Pharma saw volatile trading on Wednesday, swinging between gains and losses after the company unveiled ...

After three years of mounting pressure from AIDS activists, the pharma companies finally dropped their case. While this story has a happy ending, Mandela’s battle against Big Pharma was only a ...

Recent health news highlights include Novavax's $200 million sale of its Czech unit, UnitedHealth's higher medical cost ...

Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.